Sign in
4

Changes in Ownership

Jade Biosciences, Inc. Filed Acc 0001415889-24-013630

CHIEF MEDICAL OFFICER sold 4,000 shares at an average $21.08 ($84,332)

  • CHIEF MEDICAL OFFICER acquired 4,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Gillies Hunter · CHIEF MEDICAL OFFICER

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-17 Exercise or conversion : show line 1 in the form 10b5-1 +4,000 $2.14 $8,560 9,602 D
2024-05-17 Sale : show line 2 in the form 10b5-1 −3,914 $21.07 $82,452 5,688 D
2024-05-17 Sale : show line 3 in the form 10b5-1 −86 $21.86 $1,880 5,602 D
Open-market sales · 4,000 sh · avg $21.08 · $84,332

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-17 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) −4,000 11,324 D
Loading xslF345X05/form4-05172024_070505.xml…